Navigation Links
Drug Herceptin To Be Recommended To All Breast Cancer Patients

The drug Herceptin is to be recommended for breast cancer patients, who show positive for Her-2/neu. The presence of Her-2/neu indicates that the patient is positive, and they have a more resistant and active breast cancer, // about 30% of breast cancer women are Her-2/neu positive and the treatment for these patients with chemotherapy or anti-estrogen therapy such as Tamoxifen does not show any significant disease reduction. These patients should be given Herceptin drug for treatment.

Health Secretary Patricia Hewitt has already ordered the National Institute for Health and Clinical Excellence (NICE), the drugs watchdog, to fast track its assessment of the wider use of Herceptin. Herceptin targets a protein called HER2, which appears to be over-abundant in some women's breast cancers. Controversy also is occurring over the usage of Herceptin with some believing that Herceptin treatment is only useful during late stage breast cancer treatment, but campaigners and critics say that the drug is useful for also early stage breast cancer patients. Primary care trusts (PCTs) is currently to fund Herceptin treatment for women with early stage breast cancer, if they so wish, but campaigners say lack of funds and official approval mean that many women who could benefit are being denied the drug.

The Government is considering Her-2/neu testing to all breast cancer patients during their breast cancer surgery, using the tissue sample obtained during the surgery procedure. The company, which makes the drug, Roche, says the application for widening the use of Herceptin cannot be made any sooner than February because data from independent research has to be evaluated before it can be submitted. Keywords: Breast cancer, Herceptin, Her-2/neu, treatment, tamoxifen, chemotherapy, anti estrogen therapy, drug, anti-cancer drug, medication, primary care trust, stage of cancer, screening, controversy.
'"/>




Page: 1

Related medicine news :

1. Nurse wins her case over use of Herceptin for her Breast cancer
2. Herceptin Is A Possible Cure For Breast Cancer
3. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
4. £6000 to be refunded to Mrs. Leese for Herceptin treatmen
5. Wangaratta Community fundraising for Herceptin drug
6. Herceptin for Early Stage Breast cancer
7. Treatment of Breast Cancer with Herceptin for Nine Weeks
8. Herceptin is the cure for early stages of breast cancer?
9. 10-year-old Pleads, Herceptin For My Mum, Please
10. Norfolk PCTs To Offer Herceptin
11. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... 2016 , ... It is vital for any lab to secure funding, and ... team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools to streamline ... operate in a GLP (Good Laboratory Practice) fashion. , With features designed to simplify ...
(Date:12/7/2016)... ... ... came time to blow out his candles on his 14th birthday, Estefano Reano had only ... team at Joe DiMaggio Children’s Hospital surprised his family with a phone call that made ... , “He was playing at home, when we got the phone call telling us there ...
(Date:12/7/2016)... ... ... One of two inventors from Glen Burnie, Md., has a granddaughter who ... is why the co-inventor and I have designed a new and better way to ... of the patent-pending AV-AIR, a device that serves as an alternative to conventional methods ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... that its fully redesigned website, which launched October 17, 2016, features comprehensive information ... design and easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology ...
(Date:12/7/2016)... City, CA (PRWEB) , ... December 07, 2016 , ... ... during the holidays and winter seasons. One major study analyzing heart attacks among ... compared to August of a given year. We would all agree of course–no time ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... PARK , Israel , December 7, 2016 ... today the signing of a memorandum of understanding with Korean company ... between the companies will assist in expediting Kadimastem,s entry into international ... innovative treatment for severe diseases in general and ALS and diabetes ... , , ...
(Date:12/7/2016)... , Dec. 7, 2016 Boehringer Ingelheim ... in patients with unresectable malignant pleural mesothelioma (MPM) ... The data, presented at the 17 th ... Vienna , showed nintedanib plus pemetrexed/cisplatin ... plus pemetrexed/cisplatin, with a significantly improved PFS (9.4 ...
(Date:12/7/2016)... , Dec. 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: ... will present a company overview at the BMO Capital Markets Prescriptions ... New York, NY . A live webcast of ... of the Ionis website.  The replay will be available within 48 ... ...
Breaking Medicine Technology: